These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cellular redox pathways as a therapeutic target in the treatment of cancer. Montero AJ; Jassem J Drugs; 2011 Jul; 71(11):1385-96. PubMed ID: 21812504 [TBL] [Abstract][Full Text] [Related]
23. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis. Cheng X; Ku CH; Siow RC Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293 [TBL] [Abstract][Full Text] [Related]
24. Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies. Mileo AM; Miccadei S Oxid Med Cell Longev; 2016; 2016():6475624. PubMed ID: 26649142 [TBL] [Abstract][Full Text] [Related]
25. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201 [TBL] [Abstract][Full Text] [Related]
26. Oxidative and nitrosative stress in the maintenance of myocardial function. Zhang Y; Tocchetti CG; Krieg T; Moens AL Free Radic Biol Med; 2012 Oct; 53(8):1531-40. PubMed ID: 22819981 [TBL] [Abstract][Full Text] [Related]
27. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species. Hadi SM; Ullah MF; Shamim U; Bhatt SH; Azmi AS Chemotherapy; 2010; 56(4):280-4. PubMed ID: 20714144 [TBL] [Abstract][Full Text] [Related]
28. Oxidative stress in bone remodelling and disease. Wauquier F; Leotoing L; Coxam V; Guicheux J; Wittrant Y Trends Mol Med; 2009 Oct; 15(10):468-77. PubMed ID: 19811952 [TBL] [Abstract][Full Text] [Related]
29. Oxidative stress and oxidative damage in chemical carcinogenesis. Klaunig JE; Wang Z; Pu X; Zhou S Toxicol Appl Pharmacol; 2011 Jul; 254(2):86-99. PubMed ID: 21296097 [TBL] [Abstract][Full Text] [Related]
30. Redox control of cellular function by thioredoxin; a new therapeutic direction in host defence. Nishinaka Y; Nakamura H; Masutani H; Yodoi J Arch Immunol Ther Exp (Warsz); 2001; 49(4):285-92. PubMed ID: 11726031 [TBL] [Abstract][Full Text] [Related]
31. Targeting Metabolic-Redox Circuits for Cancer Therapy. Wang K; Jiang J; Lei Y; Zhou S; Wei Y; Huang C Trends Biochem Sci; 2019 May; 44(5):401-414. PubMed ID: 30679131 [TBL] [Abstract][Full Text] [Related]
33. Regulation of reactive oxygen species in stem cells and cancer stem cells. Kobayashi CI; Suda T J Cell Physiol; 2012 Feb; 227(2):421-30. PubMed ID: 21448925 [TBL] [Abstract][Full Text] [Related]
34. Reactive oxygen species and the free radical theory of aging. Liochev SI Free Radic Biol Med; 2013 Jul; 60():1-4. PubMed ID: 23434764 [TBL] [Abstract][Full Text] [Related]
35. Vitamin B₂: a promising adjuvant in cisplatin based chemoradiotherapy by cellular redox management. Hassan I; Chibber S; Naseem I Food Chem Toxicol; 2013 Sep; 59():715-23. PubMed ID: 23872133 [TBL] [Abstract][Full Text] [Related]
36. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Wang CH; Wu SB; Wu YT; Wei YH Exp Biol Med (Maywood); 2013 May; 238(5):450-60. PubMed ID: 23856898 [TBL] [Abstract][Full Text] [Related]